“Pre-Closing Tax Period” means any Tax period ending on or before the Closing Date (including the Closing Date) and the pre-Closing portion of any Tax period commences before and ends after the Closing Date.
“Prepayment Amount” has the meaning set forth in Section 2.5.
“Privacy Laws” means (a) each applicable Law applicable to the protection or Processing or both of Personal Data, and includes rules relating to the U.S.-EU/Switzerland Safe Harbor, Payment Card Industry Data Security Standards, and direct marketing, e-mails, text messages or telemarketing, (b) guidance issued by a Government Entity that pertains to one of the Laws, rules or standards outlined in clause (a) and (c) industry self-regulatory principles applicable to the protection or Processing of Personal Data, direct marketing, emails, text messages or telemarketing.
“Proceeding” means any action, arbitration, audit, hearing, investigation, inquiry, litigation or suit (whether civil, criminal, administrative, judicial or investigative, whether formal or informal, whether public or private) commenced, brought, conducted or heard by or before, or otherwise involving, any Government Entity or arbitrator.
“Processing” means, with respect to data, the use, collection, processing, storage, recording, organization, adaption, alteration, transfer, retrieval, consultation, disclosure, dissemination or combination of such data.
“Purchase Price” has the meaning set forth in Section 2.5.
“Registered IP” means all Intellectual Property Rights that are registered, filed or issued under the authority of, with or by any Government Entity, including all patents, registered copyrights, registered mask works and registered trademarks and all applications for any of the foregoing.
“Regulatory Approval” means, with respect to a particular jurisdiction, an approval, license, registration, notification or Authorization by any Regulatory Authority as is necessary for the sale or commercialization of a product in such jurisdiction, excluding any approval of pricing and/or reimbursement for such product in such jurisdiction. For clarity, references in this Agreement to Regulatory Approval include a clearance issued by the FDA under Section 510(k) of the FDCA, premarket approval issued by the FDA under Section 515 of the FDCA and CE marking in the European Union.
“Regulatory Authority” means any applicable federal, national, multinational, regional, state, provincial or local agency, department, bureau, commission, council, or other Government Entity, regulating or otherwise exercising authority with respect to medical devices. For clarity, references in this Agreement to Regulatory Authority includes the FDA and any foreign equivalent thereof.
“Related Party” has the meaning set forth in Section 3.18.
“Related to the Business” means primarily used in, held primarily for use in, required for or necessary to the conduct of the Business as conducted by Sellers and their Affiliates prior to the Closing and as contemplated to be conducted by Sellers or their Affiliates.
“Remaining Retained Amount” has the meaning set forth in Section 7.7(g).
“Representative” means with respect to a particular Person, any director, officer, manager, agent, consultant, advisor, accountant, financial advisor, legal counsel or other Person operating under the direction of such Person.
11